Darovasertib is an Orally Active PKC Inhibitor for Uveal Melanoma Research
Uveal melanoma (UM) is a common type of primary intraocular cancers. Besides, primary uveal melanoma...
Uveal melanoma (UM) is a common type of primary intraocular cancers. Besides, primary uveal melanoma...
Nowadays, Checkpoint inhibitors for cancer therapy have shown great benefits. Besides, amino acid metabolism is...
The ubiquitous Gαq subunit, a known transducer of plasma membrane G protein-coupled receptors signaling, is...
MEK (Mitogen-activated protein kinase kinase, MAPKK) is a kinase enzyme that phosphorylates mitogen-activated protein kinases...
v-Raf murine sarcoma viral oncogene homolog B (BRAF) is the part of the mitogen-activated protein...
Wnt5a (Wnt Family Member 5A) is a signaling molecule and is implicated in many different...
Melanoma is an immunologic malignancy characterized by higher prevalence in immune-compromised patients. In addition, once...
Melanoma is a type of skin cancer that is caused by a malignant proliferation of...
Malignant melanoma represents the most aggressive and deadliest form of cutaneous cancer. This disease possesses...
Activating mutations in NRAS account for 20%-30% of melanoma. but, there are no effective anti-NRAS...